Killing Cancer - Precisely

Precise targeting, accurate ablation. Use our High Resolution Optical Coherence Tomography (HROCT).

Our ultra-compact probe and precise 1μm and real-time guided laser ablation can significantly eliminate the limitation of MRI and more clearly analyze lesions compared to traditional optical coherence tomography (OCT).

Ultra-compact probe

Measuring 130-230 micrometers (μm), suitable for different kinds of puncture needles and 1um pathological level resolution.

Ablate tumor tissue

Our platform can accurately guide various thermal ablation treatments, ensuring 5mm+ minimal resection margin to eliminate tumor residues and block local tumor progression.

Fiber-optic robot

Our robot can be used in complex, restricted human diagnosis working environments thanks to its ultra-fine mechanical body with a 600μm outer diameter and a 360° wide-angle freedom of movement.

Smart needle probe

Our smart needle probe (SNP) technology can realize the need for pathological diagnosis at any time.

About Us

Precision, Accuracy at Micro-Level

Being innovators of in vivo pathology imaging diagnostic technology, our first integrated diagnosis platform based on ultrahigh-resolution OCT (HROCT) and ultrahigh-depth OCT (HDOCT) can be extended to multiple clinical fields. Our ultra-compact probe of 130-230μm and 1μm pathological-level resolution can better analyze lesions compared to present technologies.

 

The platform can accurately guide various thermal ablation treatments to eliminate tumor residues and block local tumor progression and significantly remove the limitation of MRI. The market for neurosurgical laser interstitial thermal therapy (LITT) is still blank. Our HROCT platform allows precise 1μm, real-time guided laser ablation and the first-generation principle prototype has been completed.

Ultrahigh-Resolution System

SNP with various applications

The diameter of our smart needle probe (SNP) catheter is less than one-fifth of OCT, about 300μm after encapsulation, which has a wide range of applications.

Ultrahigh resolution

Ultrahigh-resolution spectral domain SNP system with an imaging depth of 5mm, nearly twice that of OCT, and a resolution of 1μm (pathological level), or 10 times that of OCT.

Ultrahigh depth

Ultrahigh-depth sweep SNP system with an imaging depth of 2-4cm (ultrasonic probe level) nearly 8-16 times that of OCT, and a resolution of 6μm twice that of OCT.

Quickly reaching lesions at all levels

Our ultrahigh-resolution system provides real-time 1μm pathological-level microscopic imaging, which can be installed in various puncture needles to reach parenchymal lesions at all levels quickly.

Accessing complex natural channel

Our ultra-depth system provides a real-time centimeter-level depth of quasi-pathological microscopic imaging, which can reach complex or terminal natural channel, as well as 25 times the resolution of the same depth ultrasonic probe.

For multiple organs

Suitable for multiple organs, such as nerves, lungs, kidneys, breasts, heart and digestive tract, bringing brand-new solutions for clinical diagnosis and treatment.

RECENT NEWS

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients

Services

From diagnosis to treatment

At present, our smart needle probe (SNP) technology can only realize the need for pathological diagnosis at any time with the multi-degree of freedom movement. If combined with LITT products, we also hope to develop robots that can integrate into the catheter of LITT while pathological diagnosis, realizing the theranostic clinical purpose.